Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
While no clinical trials have directly compared Wegovy vs phentermine, available evidence from separate trials suggests that Wegovy leads to more weight loss than phentermine
A 50% reduction in manual pharmacist review allows greater focus on clinical validation and patient care. This system is purposebuilt for pharmacy complexity, not generic text translation
Metabolism The metabolism of TPM involves hydroxylation, hydrolysis, and glucuronidation